Cerebral palsy (CP) is currently considered as a clinically defined symptom complex applied to individuals with a static, nonprogressive motor impairment of early onset that is cerebral in origin. It describes a group of motor impairment syndromes secondary to genetic and acquired disorders of the developing brain. Therefore, it is not a single entity with respect to pathogenesis but rather an etiologically heterogeneous entity with multiple possible causes that result in an aberration or injury to the maturing central nervous system. The motor disorders of cerebral palsy are often accompanied by disturbances of sensation, cognition, communication, perception, and/or behavior and/or by a seizure disorder. The prevalence is estimated between 1.5 and 2.5 per 1,000 live births (Ferriero 1999).
KeywordsOsteoporosis Migraine Cardiomyopathy Meningitis Glaucoma
- Ashwal, S., Russman, B. S., Blasco, P. A., et al. (2004). Practice parameter: Diagnostic assessment of the child with cerebral palsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology, 62, 851–863.CrossRefPubMedGoogle Scholar
- Chinnery, D. F. (2014). Mitochondrial disorders overview. GeneReviews. Updated August 14, 2014. Available at UTP: http://www.ncbi.nlm.nih.gov/books/BNBK1224/.
- Panteliadis, C. P. (2004). Classification. In C. P. Panteliadis > H. M. Strassburg (Eds.), Cerebral palsy: Principles and management. Stuttgart: Thieme.Google Scholar